Office of the Secretary; Notice of Meeting, 34166 [2023-11230]
Download as PDF
<![CDATA[
34166
Federal Register / Vol. 88, No. 102 / Friday, May 26, 2023 / Notices
collections of information are subject to
review by OMB under the PRA. The
collections of information in 21 CFR
part 312 have been approved under
OMB control number 0910–0014.
DATES:
III. Electronic Access
Persons with access to the internet
may obtain the draft guidance at https://
www.fda.gov/drugs/guidancecompliance-regulatory-information/
guidances-drugs, https://www.fda.gov/
regulatory-information/search-fdaguidance-documents, or https://
www.regulations.gov.
ADDRESSES:
Dated: May 23, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023–11321 Filed 5–25–23; 8:45 am]
The meeting will be held on
Wednesday, June 28 from
approximately 12 p.m.–9 p.m. (ET) and
Thursday, March 29 from approximately
12 p.m.–6 p.m. (ET).
The meeting will be located
at the Kimpton Hotel, Palomar Phoenix
located at 2 East Jefferson Street,
Phoenix, AZ 85004. To attend the
meeting virtually, please visit
www.hhs.gov/live.
Ms.
Caroline Talev, MPA, Senior
Management Analyst, at PACHA@
hhs.gov or Caroline.Talev@hhs.gov.
Additional information can be obtained
by accessing the Council’s page on the
HIV.gov site at www.hiv.gov/pacha.
FOR FURTHER INFORMATION CONTACT:
BILLING CODE 4164–01–P
PACHA
was established by Executive Order
12963, dated June 14, 1995, as amended
by Executive Order 13009, dated June
14, 1996 and is currently operating
under the authority given in Executive
Order 14048, dated September 30, 2021.
The Council was established to provide
advice, information, and
recommendations to the Secretary
regarding programs and policies
intended to promote effective HIV
diagnosis, treatment, prevention, and
quality care services. The functions of
the Council are solely advisory in
nature. The Council consists of not more
than 35 members. Council members are
selected from prominent community
leaders with particular expertise in, or
knowledge of, matters concerning HIV
and AIDS, public health, global health,
population health, philanthropy,
marketing or business, as well as other
national leaders held in high esteem
from other sectors of society. PACHA
selections also include persons with
lived HIV experience and racial/ethnic
and sexual and gender minority persons
disproportionately affected by HIV.
Council members are appointed by the
Secretary.
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Presidential Advisory
Council on HIV/AIDS
Department of Health and
Human Services, Office of the Secretary,
Office of the Assistant Secretary for
Health.
ACTION: Notice of a hybrid meeting.
AGENCY:
As stipulated by the Federal
Advisory Committee Act, the U.S.
Department of Health and Human
Service is hereby giving notice that the
Presidential Advisory Council on HIV/
AIDS (PACHA or the Council) will
convene the 77th full council meeting
on Wednesday, June 28 and Thursday
June 29, 2023. The meeting will
convene in Phoenix, Arizona and it will
also utilize virtual technologies. The
meeting will be open to the public. Due
to limited space, pre-registration is
encouraged for members of the public
who wish to attend the meeting inperson. Please email your name to
PACHA@hhs.gov by close of business
Tuesday, June 20, 2023 to pre-reigster.
There will be a public comment session
during the meeting; pre-registration is
required to provide public comment. To
pre-register to provide public comment,
please send an email to PACHA@
hhs.gov and include your name,
organization, and title by close of
business June 20, 2023. If you decide
you would like to provide public
comment but do not pre-register, you
may submit your written statement by
emailing PACHA@hhs.gov by close of
business July 12, 2023. The meeting
agenda will be posted on the PACHA
page on HIV.gov at https://www.hiv.gov/
federal-response/pacha/about-pacha
prior to the meeting.
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
18:14 May 25, 2023
Jkt 259001
Dated: May 17, 2023.
Caroline Talev,
Senior Management Analyst, Office of
Infectious Disease and HIV/AIDS Policy,
Alternate Designated Federal Official,
Presidential Advisory Council on HIV/AIDS,
Office of the Assistant Secretary for Health,
Department of Health and Human Services.
[FR Doc. 2023–11250 Filed 5–25–23; 8:45 am]
National Institutes of Health
Office of the Secretary; Notice of
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Interagency Pain
Research Coordinating Committee.
The meeting will be held as a virtual
meeting and will be open to the public
as indicated below. Individuals who
plan to view the virtual meeting and
need special assistance or other
reasonable accommodations to view the
meeting, should notify the Contact
Person listed below in advance of the
meeting. The meeting can be accessed
from the NIH Videocast at the following
link: https://videocast.nih.gov/.
Name of Committee: Interagency Pain
Research Coordinating Committee (IPRCC).
Date: June 23, 2023.
Time: 11:00 a.m. to 12:30 p.m. Eastern
Time (ET).
Agenda: The meeting will cover committee
business items and IPRCC member updates.
Items discussed will include updates on the
Helping to End Addiction Long-Term (HEAL)
Initiative and the Federal Pain Research
Strategy (FPRS) research progress, and an
update from the Centers for Medicare and
Medicaid Services (CMS).
Deadline: Submission of intent to submit
written/electronic statement for comments:
Friday, June 16 by 5:00 p.m. ET.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Linda L. Porter, Ph.D.,
Director, Office of Pain Policy, and Planning,
Office of the Director, National Institute of
Neurological Disorders and Stroke, NIH, 31
Center Drive, Room 8A31, Bethesda, MD
20892.
Phone: (301) 451–4460.
Email: Linda.Porter@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
The meeting will be open to the public via
NIH Videocast https://videocast.nih.gov/.
Visit the IPRCC website for more
information: https://iprcc.nih.gov. Agenda and
any additional information for the meeting
will be posted when available.
Dated: May 22, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4150–43–P
PO 00000
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2023–11230 Filed 5–25–23; 8:45 am]
BILLING CODE 4140–01–P
Frm 00041
Fmt 4703
Sfmt 9990
E:\FR\FM\26MYN1.SGM
26MYN1
]]>Agencies
[Federal Register Volume 88, Number 102 (Friday, May 26, 2023)]
[Notices]
[Page 34166]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-11230]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Secretary; Notice of Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Interagency Pain
Research Coordinating Committee.
The meeting will be held as a virtual meeting and will be open to
the public as indicated below. Individuals who plan to view the virtual
meeting and need special assistance or other reasonable accommodations
to view the meeting, should notify the Contact Person listed below in
advance of the meeting. The meeting can be accessed from the NIH
Videocast at the following link: https://videocast.nih.gov/.
Name of Committee: Interagency Pain Research Coordinating
Committee (IPRCC).
Date: June 23, 2023.
Time: 11:00 a.m. to 12:30 p.m. Eastern Time (ET).
Agenda: The meeting will cover committee business items and
IPRCC member updates. Items discussed will include updates on the
Helping to End Addiction Long-Term (HEAL) Initiative and the Federal
Pain Research Strategy (FPRS) research progress, and an update from
the Centers for Medicare and Medicaid Services (CMS).
Deadline: Submission of intent to submit written/electronic
statement for comments: Friday, June 16 by 5:00 p.m. ET.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Linda L. Porter, Ph.D., Director, Office of Pain
Policy, and Planning, Office of the Director, National Institute of
Neurological Disorders and Stroke, NIH, 31 Center Drive, Room 8A31,
Bethesda, MD 20892.
Phone: (301) 451-4460.
Email: [email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
The meeting will be open to the public via NIH Videocast https://videocast.nih.gov/. Visit the IPRCC website for more information:
https://iprcc.nih.gov. Agenda and any additional information for the
meeting will be posted when available.
Dated: May 22, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-11230 Filed 5-25-23; 8:45 am]
BILLING CODE 4140-01-P
